Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9
Authors:
- 2 March 2009
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 44 (5) , 295-302
Abstract
Toll-like receptor 9 (TLR9) is part of the innate immune system, which is activated by CpG oligonucleotides (ODNs) and produces potent Th1-type innate and adaptive immune responses. It is reported that TLR9 gene variants, T1486C and T1237C, are associated with a reduced TLR9 expression compared with the wild-type gene. In two cohort analyses, we evaluated the influence of these gene variants on the outcome of transplant in 413 patients and donors. A retrospective analysis of the first cohort (n=293) showed that the homozygous CC gene variant of TLR9 (1486) compared with TC/TT gene variants was significantly associated with a markedly improved 5-year TRM (11.7 versus 36.4%, PPPn=120) and multivariate analyses confirmed the influence of the CC gene variant on these end points. Compared with patients with TC/TT gene at position 1486 of TLR9, patients with the homozygous CC gene variant had a lower TLR9 mRNA expression and a delayed T-cell immune reconstitution after transplant, which might prevent them from overwhelming immune responses as sepsis or systemic inflammatory response syndrome (SIRS) associated with an increased TRM. In vitro studies using CpG-rich ODNs showed an upregulation of TLR9 expression in cell lines with CC gene variant, but not in cell lines with wild-type gene.Keywords
This publication has 28 references indexed in Scilit:
- Relation of an interleukin-23 receptor gene polymorphism to graft-versus-host disease after hematopoietic-cell transplantationBone Marrow Transplantation, 2008
- Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathyAmerican Heart Journal, 2007
- TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting functionEuropean Journal of Immunology, 2007
- Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese populationAnnals of the Rheumatic Diseases, 2007
- Ligand-induced conformational changes allosterically activate Toll-like receptor 9Nature Immunology, 2007
- Use of the Activating Gene Mutation of the Tyrosine Kinase (VAL617Phe) JAK2 as a Minimal Residual Disease Marker in Patients With Myelofibrosis and Myeloid Metaplasia After Allogeneic Stem Cell TransplantationTransplantation, 2007
- Common human Toll‐like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevanceClinical & Experimental Allergy, 2005
- Sequence requirements for oligodeoxyribonucleotide inhibitory activityInternational Immunology, 2005
- Toll-like receptors and innate immunityNature Reviews Immunology, 2001
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958